Details for New Drug Application (NDA): 209662
✉ Email this page to a colleague
NDA 209662 describes KLOR-CON, which is a drug marketed by Upsher Smith Labs and is included in four NDAs. It is available from seven suppliers. Additional details are available on the KLOR-CON profile page.
The generic ingredient in KLOR-CON is potassium chloride. There are two hundred and forty drug master file entries for this compound. Eighty-eight suppliers are listed for this compound. Additional details are available on the potassium chloride profile page.
The generic ingredient in KLOR-CON is potassium chloride. There are two hundred and forty drug master file entries for this compound. Eighty-eight suppliers are listed for this compound. Additional details are available on the potassium chloride profile page.
Summary for 209662
| Tradename: | KLOR-CON |
| Applicant: | Upsher Smith Labs |
| Ingredient: | potassium chloride |
| Patents: | 0 |
Pharmacology for NDA: 209662
| Mechanism of Action | Osmotic Activity |
| Physiological Effect | Increased Large Intestinal Motility Inhibition Large Intestine Fluid/Electrolyte Absorption |
Suppliers and Packaging for NDA: 209662
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| KLOR-CON | potassium chloride | FOR SOLUTION;ORAL | 209662 | ANDA | Upsher-Smith Laboratories, LLC | 0245-0360 | 0245-0360-01 | 100 PACKET in 1 CARTON (0245-0360-01) / 1 POWDER, FOR SOLUTION in 1 PACKET (0245-0360-89) |
| KLOR-CON | potassium chloride | FOR SOLUTION;ORAL | 209662 | ANDA | Upsher-Smith Laboratories, LLC | 0245-0360 | 0245-0360-30 | 30 PACKET in 1 CARTON (0245-0360-30) / 1 POWDER, FOR SOLUTION in 1 PACKET (0245-0360-89) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | FOR SOLUTION;ORAL | Strength | 20MEQ | ||||
| Approval Date: | Oct 23, 2017 | TE: | AA | RLD: | No | ||||
Complete Access Available with Subscription
